Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art

Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759 · see citing works

Solid lipid nanoparticles Production, characterization and applications

Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,158 · see citing works

Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants

Koppel, D. E. (1972) · The Journal of Chemical Physics · doi:10.1063/1.1678153 · Cited by 2,883 · see citing works

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system

Ungerstedt, U., & Arbuthnott, G. W. (1970) · Brain Research · doi:10.1016/0006-8993(70)90187-3 · Cited by 1,993 · see citing works

Nanoparticulate systems for brain delivery of drugs.

Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · see citing works

Nanoparticulate systems for brain delivery of drugs

Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958 · see citing works

A Clinicopathologic Study of 100 Cases of Parkinson's Disease

Hughes, A. J., Daniel, S. E., Blankson, S., & Lees, A. J. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540020018011 · Cited by 945 · see citing works

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

Schwarting, R. K. W., & Huston, J. P. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00040-8 · Cited by 741 · see citing works

Dynamic Light Scattering Measurement of Nanometer Particles in Liquids

Pecora, R. (2000) · Journal of Nanoparticle Research · doi:10.1023/a:1010067107182 · Cited by 621 · see citing works

Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential

Westesen, K., Bunjes, H., & Koch, M. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00046-1 · Cited by 539 · see citing works

Cubic phases of lipid-containing systems

Mariani, P., Luzzati, V., & Delacroix, H. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90607-9 · Cited by 481 · see citing works

Levodopa motor complications in Parkinson's disease

Obeso, J. A., Olanow, C. W., & Nutt, J. G. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00031-8 · Cited by 478 · see citing works

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain

Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 475 · see citing works

Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy

Jores, K., Mehnert, W., Drechsler, M., Bunjes, H., Johann, C., & Mäder, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.012 · Cited by 473 · see citing works

Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles

Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352 · see citing works

The catalepsy test: Its ups and downs.

Sanberg, P. R., Bunsey, M. D., Giòrdano, M., et al. (1988) · Behavioral Neuroscience · doi:10.1037//0735-7044.102.5.748 · Cited by 323 · see citing works

The catalepsy test: Its ups and downs.

Sanberg, P. R., Bunsey, M. D., Giòrdano, M., et al. (1988) · Behavioral Neuroscience · doi:10.1037/0735-7044.102.5.748 · Cited by 322 · see citing works

Colloidal carriers and blood–brain barrier (BBB) translocation: A way to deliver drugs to the brain?

García-García, E., Andrieux, K., Gil, S., & Couvreur, P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.031 · Cited by 314 · see citing works

A review of the receptor-binding and pharmacokinetic properties of dopamine agonists

Kvernmo, T., Härtter, S., & Bürger, E. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.08.004 · Cited by 279 · see citing works

Treatment interventions for Parkinson's disease: an evidence based assessment

Rascol, O., Goetz, C. G., Koller, W. C., Poewe, W. H., & Sampaio, C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08520-3 · Cited by 279 · see citing works

Nanoparticle Technology for Delivery of Drugs Across the Blood–Brain Barrier

Schröeder, U., Sommerfeld, P., Ulrich, S., & Sabel, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980084y · Cited by 275 · see citing works

Brain uptake of thiamine-coated nanoparticles

Lockman, P. R., Oyewumi, M. O., Koziara, J. M., Roder, K. E., Mumper, R. J., & Allen, D. D. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.006 · Cited by 260 · see citing works

Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting

Brigger, I., Morizet, J., Aubert, G., Chacun, H., Terrier‐Lacombe, M., Couvreur, P., & Vassal, G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039669 · Cited by 234 · see citing works

De novo administration of ropinirole and bromocriptine induces less dyskinesia than L ‐dopa in the MPTP‐treated marmoset

Pearce, R. K. B., Banerji, T., Jenner, P. G., & MARSDEN, C. D. (1998) · Movement Disorders · doi:10.1002/mds.870130207 · Cited by 218 · see citing works

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

Olivier, J.-C., Fenart, L., Chauvet, R., Pariat, C., Cecchelli, R., & Couet, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018947208597 · Cited by 213 · see citing works

A review of nanocarrier-based CNS delivery systems.

Tiwari, S. B., & Amiji, M. (2006) · Current Drug Delivery · doi:10.2174/156720106776359230 · Cited by 200 · see citing works

In Situ Blood–Brain Barrier Transport of Nanoparticles

Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003374.58641.62 · Cited by 182 · see citing works

Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat

Calvo, P., Gouritin, B., Villarroya, H., Eclancher, F., Giannavola, C., Klein, C., Andreux, J. P., & Couvreur, P. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01967.x · Cited by 164 · see citing works

Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization

Jenning, V., Lippacher, A., & Gohla, S. (2002) · Journal of Microencapsulation · doi:10.1080/713817583 · Cited by 163 · see citing works

Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems

Bodor, N. S., & Buchwald, P. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00090-8 · Cited by 158 · see citing works

Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles

Lippacher, A., Müller, R. H., & Mäder, K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00623-2 · Cited by 157 · see citing works

Production of solid lipid nanoparticles (SLN): scaling up feasibilities

Dingler, A., & Gohla, S. (2002) · Journal of Microencapsulation · doi:10.1080/02652040010018056 · Cited by 145 · see citing works

Lipid-based supramolecular systems for topical application: A preformulatory study

Esposito, E., Eblovi, N., Rasi, S., et al. (2003) · AAPS PharmSci · doi:10.1208/ps050430 · Cited by 141 · see citing works

Drug delivery to damaged brain

Lo, E. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00083-2 · Cited by 136 · see citing works

New Technologies for Drug Delivery Across the Blood Brain Barrier

Kabanov, A. V., & Batrakova, E. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384826 · Cited by 133 · see citing works

Blockade of Nociceptin/Orphanin FQ Transmission Attenuates Symptoms and Neurodegeneration Associated with Parkinson's Disease

Marti, M., Mela, F., Fantin, M., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2546-05.2005 · Cited by 120 · see citing works

Incorporation of the Model Drug Ubidecarenone into Solid Lipid Nanoparticles

Bunjes, H., Drechsler, M., Koch, M. H. J., & Westesen, K. (2001) · Pharmaceutical Research · doi:10.1023/a:1011042627714 · Cited by 95 · see citing works

The blood–brain barrier efflux transporters as a detoxifying system for the brain

Terasaki, T., & Hosoya, K. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00088-x · Cited by 93 · see citing works

REVIEW

Obeso, J. A., Grandas, F., Herrero, M. T., & HOROWSKI, R. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00584.x · Cited by 83 · see citing works

The Nociceptin/Orphanin FQ Receptor Antagonist J-113397 and l-DOPA Additively Attenuate Experimental Parkinsonism through Overinhibition of the Nigrothalamic Pathway

Marti, M., Trapella, C., Viaro, R., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4346-06.2007 · Cited by 77 · see citing works

Mechanisms regulating body distribution of nanospheres conditioned with pluronic and tetronic block co-polymers

Moghimi, S. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00024-2 · Cited by 72 · see citing works

Brain drug delivery technologies: novel approaches for transporting therapeutics

Temsamani, J., Scherrmann, J., Rees, A. R., & Kaczorek, M. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00258-3 · Cited by 66 · see citing works

Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?

Lane, E. L., Cheetham, S. C., & Jenner, P. G. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.06.006 · Cited by 65 · see citing works

[Optimization of the preparation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine pharmacosomes using central composite design].

Zr, Z., Jx, W., & Lü, J. (2001) · PubMed · Cited by 12 · see citing works

Study on Bone Marrow Targeting Daunorubicin Polybutylcyanoacrylate Nanoparticles

Ying, P. (2000) · Chinese Journal of Pharmaceuticals · Cited by 3 · see citing works

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works

Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems

Kuntsche, J., Horst, J. C., & Bunjes, H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.001 · Cited by 363 · see citing works

Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB

Satapathy, M. K., Yen, T.-L., Jan, J.-S., Tang, R.-D., Wang, J.-Y., Taliyan, R., & Yang, C.-H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081183 · Cited by 318 · see citing works

Solid lipid nanoparticles loaded with lipoyl–memantine codrug: Preparation and characterization

Laserra, S., Basit, A., Sozio, P., Marinelli, L., Fornasari, E., Cacciatore, I., Ciulla, M., Türkez, H., Geyikoglu, F., & Di Stefano, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.03.001 · Cited by 72 · see citing works

Cryogenic transmission electron microscopy for direct observation of polymer and small-molecule materials and structures in solution

Zhong, S., & Pochan, D. J. (2010) · Polymer Reviews · doi:10.1080/15583724.2010.493254 · Cited by 51 · see citing works

Treatment of Acromegaly with Bromocriptine

Steinbeck, K. S., & Turtle, J. R. (1978) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1978.tb77389.x

[Anti-tumorous effect of bromocriptine in prolactin-secreting adenomas. A case-report (author's transl)].

Jc, B., Rohmer, Mercier, P., et al. (1982) · PubMed

[Bromocriptine in Parkinsonian syndromes. Results obtained in a group of patients treated for 8 months].

Quattrini, A., Paggi, A., Del Pesce, M., et al. (1979) · PubMed

[Use of low doses of bromocriptine in chronic schizophrenia resistant to neuroleptics. A preliminary study].

Wolf, M. A., Diener, J.-M., Lajeunesse, C., et al. (1992) · PubMed · Cited by 4 · see citing works

Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.

Breidahl, H. D., Topliss, D. J., & Pike, J. W. (1983) · BMJ · doi:10.1136/bmj.287.6390.451 · Cited by 62 · see citing works